Body iron stores in relation to risk of type 2 diabetes in apparently healthy women

被引:448
作者
Jiang, R
Manson, JE
Meigs, JB
Ma, J
Rifai, N
Hu, FB
机构
[1] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA
[2] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Div Prevent Med, Boston, MA USA
[4] Harvard Univ, Sch Med, Dept Med, Boston, MA USA
[5] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
[6] Brigham & Womens Hosp, Div Gen Med, Boston, MA 02115 USA
[7] Channing Labs, Boston, MA USA
[8] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA
[9] Childrens Hosp, Med Ctr, Boston, MA 02115 USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2004年 / 291卷 / 06期
关键词
D O I
10.1001/jama.291.6.711
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Type 2 diabetes is a common manifestation of hemochromatosis, a disease of iron overload. However, it is not clear whether higher iron stores predict the development of type 2 diabetes in a healthy population. Objective To examine plasma ferritin concentration and the ratio of the concentrations of transferrin receptors to ferritin in relation to risk of type 2 diabetes. Design, Setting, and Participants Prospective nested case-control study within the Nurses' Health Study cohort. Of the 32826 women who provided blood samples during 1989-1990 and were free of diagnosed diabetes, cardiovascular disease, and cancer, 698 developed diabetes during 10 years of follow-up. The controls (n=716) were matched to cases on age, race, and fasting status; and on body mass index (BMI) for cases in the top BMI decile. Main Outcome Measure Incident cases of type 2 diabetes. Results Among cases, the mean (SD) concentration of ferritin was significantly higher (109 [1051 vs 71.5 [68.7] ng/mL for controls; P<.001 for difference) and the mean (SD) ratio of transferrin receptors to ferritin was significantly lower (102 [205] vs 141 [340], respectively; P=.01). In conditional logistic regression stratified on the matching factors and controlled for BMI and other diabetes risk factors, the multivariate relative risks [RRs] of incident type 2 diabetes across increasing quintiles of ferritin were 1.00, 1.09 (95% confidence interval [CI], 0.70-1.70),1.26 (95% Cl, 0.82-1.95),1.30 (95% Cl, 0.83-2.04), and 2.68 (95% Cl, 1.75-4.11) (P<.001 for trend). The RRs across increasing quintiles of transferrin receptors to ferritin ratio were 2.44 (95% Cl, 1.61-3.71), 1.00 (95% Cl, 0.64-1.56),1.13 (95% Cl, 0.73-1.74), 0.99 (95% Cl, 0.64-1.53), and 1.00 (P=.01 for trend). Further adjustment for an inflammatory marker (C-reactive protein) did not change the results appreciably. The associations persisted within strata defined by levels of BMI, menopausal status, alcohol consumption, and C-reactive protein. Conclusion Higher iron stores (reflected by an elevated ferritin concentration and a lower ratio of transferrin receptors to ferritin) are associated with an increased risk of type 2 diabetes in healthy women independent of known diabetes risk factors.
引用
收藏
页码:711 / 717
页数:7
相关论文
共 31 条
[1]   Medical progress: Disorders of iron metabolism [J].
Andrews, NC .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (26) :1986-1995
[2]   Iron biology in immune function, muscle metabolism and neuronal functioning [J].
Beard, JL .
JOURNAL OF NUTRITION, 2001, 131 (02) :568S-579S
[3]   Reproducibility and validity of a self administered physical activity questionnaire for male health professionals [J].
ChasanTaber, S ;
Rimm, EB ;
Stampfer, MJ ;
Spiegelman, D ;
Colditz, GA ;
Giovannucci, E ;
Ascherio, A ;
Willett, WC .
EPIDEMIOLOGY, 1996, 7 (01) :81-86
[4]   The Nurses' Health Study: 20-year contribution to the understanding of health among women [J].
Colditz, GA ;
Manson, JE ;
Hankinson, SE .
JOURNAL OF WOMENS HEALTH, 1997, 6 (01) :49-62
[5]   DEFEROXAMINE THERAPY IN HIGH-FERRITIN DIABETES [J].
CUTLER, P .
DIABETES, 1989, 38 (10) :1207-1210
[6]   FLEXIBLE REGRESSION-MODELS WITH CUBIC-SPLINES [J].
DURRLEMAN, S ;
SIMON, R .
STATISTICS IN MEDICINE, 1989, 8 (05) :551-561
[7]   Serum ferritin as a component of the insulin resistance syndrome [J].
Fernández-Real, JM ;
Ricart-Engel, W ;
Arroyo, E ;
Balançá, R ;
Casamitjana-Abella, R ;
Cabrero, D ;
Fernández-Castañer, M ;
Soler, J .
DIABETES CARE, 1998, 21 (01) :62-68
[8]   Diabetes and serum ferritin concentration among US adults [J].
Ford, ES ;
Cogswell, ME .
DIABETES CARE, 1999, 22 (12) :1978-1983
[9]  
Gavin JR, 1997, DIABETES CARE, V20, P1183
[10]  
HARRIS M, 1979, DIABETES, V28, P1039